NCT00869271已完成4 期
Postoperative folfox4 Only vs folfox4 Plus TAC in the Treatment Unresectable Liver Metastasis of Colorectal Cancer: a Randomized,Prospective,Control Trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- overall survival
研究概览
简要总结
The purpose of this study is to investigate whether TAC plus FOLFOX4 are able to improve resection rate and overall survival in patients receiving primary colorectal tumor resection than given FOLFOX4 only.
详细描述
We administered three cycles FOLFOX4 plus on TAC (oxaliplatin, FUDR and MMC) or FOLFOX4 only to primary colorectal tumor resected patients with unresected liver metastasis. The study endpoints were resection rate of liver metastasis, progression-free survival, overall survival as evaluated by intent-to-treat analysis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age < 75 years with histologically proven adenocarcinoma of the colon or rectum
- •no severe major organ dysfunction
- •WHO performance status of 0 or 1
- •no prior cancer therapy
- •with measurable unresectableliver metastasis
- •without other metastasis
排除标准
- •age >= 75
- •severe major organ dysfunction
- •WHO performance status of >1
- •prior cancer therapy
- •with other metastasis
结局指标
主要结局
overall survival
时间窗: 5 years after diagnosis
次要结局
- progression free survival(5 years after diagonsis)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
4 期
Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal CancerLiver MetastasisColorectal CancerNCT00868569Fudan University200
已完成
2 期
A phase II study of Perioperative FOLFOX4 plus Bevacizumab for initially unresectable Advanced Colorectal Cancer.colorectal cancerJPRN-UMIN000005572Japanese foundation for cancer research49
进行中（未招募）
1 期
FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for local failureocally advanced rectal adenocarcinoma localized 0 - 16 cm from the anal verge with low risk of local failureMedDRA version: 20.0Level: LLTClassification code 10038052Term: Rectal carcinomaSystem Organ Class: 100000004864EUCTR2018-001356-35-DEniversity of Heidelberg550
已完成
2 期
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group TrialPancreatic CancerNCT02022033Brown University25
已完成
2 期
Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver MetastasisUnresectable Liver MetastasisColorectal CancerNCT00743678Samsung Medical Center73